356 related articles for article (PubMed ID: 23164592)
21. Five-Year outcomes of patients enrolled in the REVEAL Registry.
Farber HW; Miller DP; Poms AD; Badesch DB; Frost AE; Muros-Le Rouzic E; Romero AJ; Benton WW; Elliott CG; McGoon MD; Benza RL
Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
[TBL] [Abstract][Full Text] [Related]
22. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.
Hoeper MM; Pausch C; Grünig E; Klose H; Staehler G; Huscher D; Pittrow D; Olsson KM; Vizza CD; Gall H; Benjamin N; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Rosenkranz S; Ewert R; Kaemmerer H; Lange TJ; Kabitz HJ; Skowasch D; Skride A; Jureviciene E; Paleviciute E; Miliauskas S; Claussen M; Behr J; Milger K; Halank M; Wilkens H; Wirtz H; Pfeuffer-Jovic E; Harbaum L; Scholtz W; Dumitrescu D; Bruch L; Coghlan G; Neurohr C; Tsangaris I; Gorenflo M; Scelsi L; Vonk-Noordegraaf A; Ulrich S; Held M
J Heart Lung Transplant; 2020 Dec; 39(12):1435-1444. PubMed ID: 33082079
[TBL] [Abstract][Full Text] [Related]
24. Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.
Strange G; Lau EM; Giannoulatou E; Corrigan C; Kotlyar E; Kermeen F; Williams T; Celermajer DS; Dwyer N; Whitford H; Wrobel JP; Feenstra J; Lavender M; Whyte K; Collins N; Steele P; Proudman S; Thakkar V; Keating D; Keogh A;
Heart Lung Circ; 2018 Nov; 27(11):1368-1375. PubMed ID: 29029950
[TBL] [Abstract][Full Text] [Related]
25. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
26. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
27. Real-world, long-term survival of incident patients with pulmonary arterial hypertension.
Marques-Alves P; Baptista R; Marinho da Silva A; Pêgo M; Castro G
Rev Port Pneumol (2006); 2017; 23(3):124-131. PubMed ID: 28283462
[TBL] [Abstract][Full Text] [Related]
28. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of clinical characteristics and survival on patients with idiopathic pulmonary arterial hypertension and familial pulmonary arterial hypertension during conventional therapy era and targeted therapy era].
Xu X; Sun M; Jiang X; Zhang R; Zhao Q; Wang Y; Sun K; Wang X; Peng F; Zheng L; Wen L; Jing Z
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):465-8. PubMed ID: 25164218
[TBL] [Abstract][Full Text] [Related]
30. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.
Sadushi-Koliçi R; Skoro-Sajer N; Zimmer D; Bonderman D; Schemper M; Klepetko W; Glatz J; Jakowitsch J; Lang IM
J Heart Lung Transplant; 2012 Jul; 31(7):735-43. PubMed ID: 22480725
[TBL] [Abstract][Full Text] [Related]
31. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
Schachna L; Medsger TA; Dauber JH; Wigley FM; Braunstein NA; White B; Steen VD; Conte JV; Yang SC; McCurry KR; Borja MC; Plaskon DE; Orens JB; Gelber AC
Arthritis Rheum; 2006 Dec; 54(12):3954-61. PubMed ID: 17133609
[TBL] [Abstract][Full Text] [Related]
32. Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.
Roofthooft MT; Douwes JM; Vrijlandt EJ; Berger RM
Am J Cardiol; 2013 Nov; 112(9):1505-9. PubMed ID: 23972345
[TBL] [Abstract][Full Text] [Related]
33. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
[TBL] [Abstract][Full Text] [Related]
34. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.
Shimony A; Eisenberg MJ; Rudski LG; Schlesinger R; Afilalo J; Joyal D; Dragatakis L; Hirsch A; Boutet K; Fox BD; Langleben D
Am J Cardiol; 2011 Aug; 108(3):460-4. PubMed ID: 21600533
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD
Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797
[TBL] [Abstract][Full Text] [Related]
38. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era.
Schaffer JM; Singh SK; Joyce DL; Reitz BA; Robbins RC; Zamanian RT; Mallidi HR
Circulation; 2013 Jun; 127(25):2503-13. PubMed ID: 23697910
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival.
Shimony A; Fox BD; Afilalo J; Rudski LG; Hirsch A; Langleben D
Lung; 2012 Dec; 190(6):645-9. PubMed ID: 23064491
[TBL] [Abstract][Full Text] [Related]
40. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
Pepke-Zaba J; Delcroix M; Lang I; Mayer E; Jansa P; Ambroz D; Treacy C; D'Armini AM; Morsolini M; Snijder R; Bresser P; Torbicki A; Kristensen B; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Hamid AM; Jaïs X; Simonneau G
Circulation; 2011 Nov; 124(18):1973-81. PubMed ID: 21969018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
